RIL
RPRX icon

Rothschild Investment LLC’s Royalty Pharma RPRX Stock Holding History

Rothschild Investment LLC’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Buy
9,213
+6,854
+291% +$357K 0.02% 593
2026
Q1 		$113K Buy
2,359
+2,323
+6,453% +$102K 0.01% 843
2025
Q4 		$1.39K Buy
36
+15
+71% +$572 ﹤0.01% 2547
2025
Q3 		$741 Buy
21
+17
+425% +$615 ﹤0.01% 2705
2025
Q2 		$144 Buy
+4
New +$133 ﹤0.01% 2963

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rothschild Investment LLC's RPRX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Royalty Pharma (RPRX) stake by 291% in Q2 2026, buying an estimated $357K and bringing the position to 9,213 shares worth $517K. The position accounts for 0.02% of the portfolio, ranked #593.

Rothschild Investment LLC first reported a position in RPRX in Q2 2025 and has held it in 5 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Rothschild Investment LLC held 9,213 shares of Royalty Pharma worth $517K as of Q2 2026.
  • Rothschild Investment LLC bought 6,854 Royalty Pharma shares in Q2 2026, an estimated $357K.
  • Royalty Pharma made up 0.02% of Rothschild Investment LLC's portfolio in Q2 2026, its #593 holding.
  • Rothschild Investment LLC first reported a position in Royalty Pharma in Q2 2025 and has held it in 5 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.